A detailed history of Allworth Financial LP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Allworth Financial LP holds 1,000 shares of SGMO stock, worth $2,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$2,040
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$0.36 - $0.65 $178 - $323
-497 Reduced 33.2%
1,000 $0
Q4 2023

Jan 24, 2024

BUY
$0.3 - $0.63 $149 - $313
497 Added 49.7%
1,497 $0
Q2 2021

Aug 02, 2021

SELL
$10.17 - $12.64 $508 - $632
-50 Reduced 4.76%
1,000 $12,000
Q1 2021

Apr 29, 2021

BUY
$10.88 - $17.05 $544 - $852
50 Added 5.0%
1,050 $13,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,000
1,000 $9,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $319M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.